Adefovir
Adefovir is an antiviral prodrug that displays immunomodulatory activity. Adefovir is an acyclonucleotide analog that inhibits viral DNA polymerase, acting as a DNA chain terminator. Adefovir is primarily used to treat hepatitis B infection, but also displays activity against retroviruses. Adefovir decreases levels of Treg cells and increases levels of IL-4, IL-2, TNF-α, and IFN-γ. Additionally, this compound may show anti-arthritic activity as well, inhibiting production of NO and expression of RANTES and acting both as a prophylactic or a rescue treatment in animal models of adjuvant-induced arthritis.
References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18835937
| Cas No. |
106941-25-7 |
|---|---|
| Purity |
≥98% |
| Formula |
C8H12N5O4P |
| Formula Wt. |
273.19 |
| IUPAC Name |
2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid |
| Appearance |
White to off white powder |
Jiang Y, Li W, Yu L, et al. Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies. Cell Mol Immunol. 2011 Jan;8(1):75-82. PMID: 20921939
Rodriguez-Frias F, Jardi R, Schaper M, et al. Adefovir for chronic hepatitis B treatment: identification of virological markers linked to therapy response. Antivir Ther. 2008;13(8):991-9. PMID: 19195324.
Zídek Z, Franková D, Holý A. Chemokines, nitric oxide and antiarthritic effects of 9-(2-phosphonomethoxyethyl)adenine (Adefovir). Eur J Pharmacol. 1999 Jul 2;376(1-2):91-100. PMID: 10440094.
Neyts J, De Clercq E. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication. Biochem Pharmacol. 1994 Jan 13;47(1):39-41. PMID: 8311844.
